Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SZSE: 002864)
Health Care · Pharmaceuticals · CN
CN¥21.05
+0.48% today · -6.9% 1Y
Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SZSE: 002864) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $432.06M and employs 926 people.
Over the last twelve months the share price has lost 6.9%, trading between 19.00 and 32.98.
Tweenvest scores Shaanxi Panlong Pharmaceutical Group Co., Ltd. across four factors: quality 75/100, value 56/100, growth 41/100, dividend 74/100. Its strongest factor is quality.
002864 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $432.06M
- Revenue (TTM)
- $145.66M
- P/E
- 36.48
- EPS
- 0.58
- Dividend yield
- 1.28%
- Beta (5Y)
- -0.27
- 52-week high
- CN¥32.98
- 52-week low
- CN¥19.00
- Avg volume (3M)
- —
- Shares outstanding
- 137.68M
- Employees
- 926
- Next earnings
- —
About Shaanxi Panlong Pharmaceutical Group Co., Ltd.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is a pharmaceutical enterprise based in China, comprehensively engaging in the research, development, production, and sale of pharmaceutical products. Furthermore, the company undertakes the GAP-compliant cultivation of medicinal raw materials. Its diverse product portfolio spans numerous therapeutic categories, including orthopedic, cardio-cerebrovascular, digestive, nutritional supplement, respiratory, Traditional Chinese Anti-Inflammatory, pediatric, gynecological, hepatobiliary, and various specialty drugs. Established in 1997, the company maintains its headquarters in Xi'an, China.
- ISIN
- CNE1000032C9
- Founded
- 1997
- Listed since
- Nov 16, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jiangxi Synergy Pharmaceutical Co., Ltd.SZSE: 300636 | $443.88M | CN¥7.09 | +0.71% |
| Shanghai Kai Kai Industry Company LimitedSHSE: 600272 | $442.88M | CN¥15.01 | -1.51% |
| Gufic Biosciences LimitedBSE: 509079 | $435.58M | Rs418.20 | -1.11% |
| AgomAb Therapeutics NVNasdaqGS: AGMB | $433.38M | $9.22 | +4.77% |
| Nika Pharmaceuticals, Inc.OTCPK: NIKA | $431.19M | $— | — |
| Guizhou Yibai Pharmaceutical Co., Ltd.SHSE: 600594 | $425.65M | CN¥3.64 | +0.83% |
| Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153 | $423.27M | CN¥6.11 | +0.33% |
| Renata PLCDSE: RENATA | $418.17M | Tk448.70 | -0.09% |
Figures last refreshed Oct 4, 2026.